QA review – Page 25 – Pharma.Tips

Incomplete CoA traceability in LIMS test assignment workflows: Data Integrity Risks and Corrective Controls

Ensuring Accurate CoA Traceability in LIMS Test Assignment Workflows: Addressing Data Integrity Risks In pharmaceutical manufacturing, ensuring the integrity of data within Laboratory Information Management Systems (LIMS) is paramount. Incomplete…

Step-by-Step Guide to Managing Manual Baseline Corrections Under ALCOA+ Expectations

Managing Manual Baseline Corrections in Compliance with ALCOA+ Standards In the realm of pharmaceutical manufacturing and quality assurance, integrity of data generated through chromatography is paramount. Errors related to manual…

Incomplete CoA traceability in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Addressing Incomplete CoA Traceability in LIMS Sample Login and Accessioning Incomplete Certificate of Analysis (CoA) traceability during sample login and accessioning in Laboratory Information Management Systems (LIMS) poses significant data…

Why Integration Parameter Locking Happens and How QA Teams Should Control It

Understanding and Controlling Integration Parameter Locking in CDS The pharmaceutical industry increasingly relies on automated data acquisition and analysis, particularly through chromatography data systems (CDS). However, issues like integration parameter…

User privilege creep in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

User Privilege Management in LIMS: Mitigating Data Integrity Risks in Stability Sample Management In modern pharmaceutical manufacturing and laboratory environments, the integrity of data collected and managed through Laboratory Information…

User privilege creep in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Addressing User Privilege Creep in LIMS: Ensuring Data Integrity in Stability Sample Pulls In the highly regulated pharmaceutical industry, ensuring the integrity of laboratory data managed through Laboratory Information Management…

Inspection-Ready Approach to CDS Access Recertification in Pharmaceutical Operations

Strategies to Mitigate CDS Access Recertification Issues in Pharmaceutical Operations In the intricate landscape of pharmaceutical operations, maintaining data integrity in Chromatography Data Systems (CDS) is critical. Frequent access recertification…

Inspection-Ready Approach to CDS Access Recertification in Pharmaceutical Operations

Effective Strategies for Addressing CDS Data Integrity Risks in Pharmaceutical Operations In the ever-evolving landscape of pharmaceutical manufacturing, ensuring the integrity of data generated from Chromatography Data Systems (CDS) is…

User privilege creep in LIMS specification management: Data Integrity Risks and Corrective Controls

Addressing User Privilege Creep in LIMS Specification Management: A Case Study on Data Integrity Risks and Corrective Actions The increasing dependence on Laboratory Information Management Systems (LIMS) has led to…

Legacy CDS Compliance: Root Causes, GMP Risks, and CAPA Controls

Addressing Legacy CDS Compliance: Identifying Root Causes and Implementing Effective CAPA Controls In pharmaceutical development and manufacturing, compliance with data integrity standards is paramount for ensuring the quality and safety…

User privilege creep in LIMS result entry and review: Data Integrity Risks and Corrective Controls

User Privilege Management in LIMS: Addressing Data Integrity Risks and Implementing Corrective Controls In the pharmaceutical industry, the integrity of laboratory data is paramount. User privilege creep in Laboratory Information…

How to Prevent Analyst Privilege Creep in CDS (Chromatography Data System) Risks

Addressing Analyst Privilege Creep in Chromatography Data Systems Analysts in pharmaceutical manufacturing often face challenges related to Chromatography Data Systems (CDS) and data integrity. A rising concern in this area…